Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+metastatic breast cancer
    Meeting Abstract

    Krop, I. E.; Beeram, M.; Modi, S.; Rabbee, N.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Burris, H. A.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with advanced HER2+ breast cancer
    Meeting Abstract

    Krop, I. E.; Beeram, M.; Modi, S.; Rabbee, N.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Burris, H. A.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • HER2: Beyond trastuzumab
    Meeting Abstract

    Hudis, C.
    Cancer Investigation (2007)

    Fulltext@MSK | Save
  • Serum Levels of N-telopepticle (sNTX) and bone-specific alkaline phosphatase (BAP) in oncology patients (pts) who developed osteonecrosis of the jaw (ONJ) during therapy with intravenous bisphosphonates (IB)
    Meeting Abstract

    Fornier, M.; Farooki, A.; Estilo, C.; Conlin, A.; Patil, S.; Fleisher, M.; Huryn, J.; Hudis, C.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Toward individualized risk prediction: The clinical benefit of risk reduction mastectomy and oophorectomy in BRCA carriers with breast cancer
    Meeting Abstract

    Burke, H. B.; Hoang, A.; Metcalfe, K.; Culver, J. O.; MacDonald, D. J.; Grant, M.; Thornton, A.; Robson, M.; Narod, S.; Weitzel, J. N.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Clinical, morphologic and immunophenotypic characteristics of primary breast carcinomas (BC) with brain metastases (BM)
    Meeting Abstract

    Brogi, E.; Murray, M. P.; Patil, S.; Akram, M.; Nehhozina, T.; Norton, L.; Seidman, A.; Tan, L. K.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Clinical, morphologic and immunophenotypic characteristics of primary breast carcinomas (BC) with brain metastases (BM)
    Meeting Abstract

    Brogi, E.; Murray, M. P.; Patil, S.; Akram, M.; Nehhozina, T.; Norton, L.; Seidman, A.; Tan, L. K.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Trastuzumab-MCC-DM1 (Tmab-MCC-DM1), a first-in-class HER2 antibody-drug conjugate (ADC) - A phase I study in patients (pts) with HER2+ metastatic breast cancer (BC)
    Meeting Abstract

    Beeram, M.; Krop, I. E.; Modi, S.; Tolcher, A. W.; Tibbitts, J.; Rabbees, N.; Girish, S.; Lutzker, S. G.; Holden, S. N.; Burris, H. A.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Decline in serum HER-2/neu predicts response to trastuzumab-based therapy
    Meeting Abstract

    Ali, S. M.; Brault, D.; Brown-Shimer, S.; Carney, W.; Esteva, F. J.; Fornier, M.; Gligorov, J.; Hamer, P.; Harris, L.; KoĢˆstler, W. J.; more...
    International Journal of Biological Markers (2007)

    Fulltext@MSK | Save
  • Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer
    Journal Article

    Thomas, E.; Tabernero, J.; Fornier, M.; Conte, P.; Fumoleau, P.; Lluch, A.; Vahdat, L. T.; Bunnell, C. A.; Burris, H. A.; Viens, P.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save